John Brooling1, Rolando Leal2. 1. Division of Gastroenterology, University of Arizona, Tucson, AZ, USA. 2. Division of Gastroenterology, Southern Arizona VA Hospital, 3601 S 6th Ave, Tucson, AZ, 85723, USA. Rolando.Leal@va.gov.
Abstract
PURPOSE OF REVIEW: Secondary sclerosing cholangitis is an emerging entity. Yet, because of the low incidence and varying etiologies of this disease, the literature is not robust. There are mainly case reports and small studies evaluating the disease. Our aim in this review is to bring the reader up to date with recent literature on secondary sclerosing cholangitis including the disease presentation, course, prognosis, and treatment options. RECENT FINDINGS: Numerous case reports have been published the last 5 years on secondary sclerosing cholangitis. We have divided them into infectious, drug-induced, ischemic, obstructive, and autoimmune etiologies. The bulk of the literature describes secondary sclerosing cholangitis in the critically ill patient. Secondary sclerosing cholangitis due to drugs or autoimmune causes seem to have the best prognosis. However, causes such as critical illness seem to have worse outcomes.
PURPOSE OF REVIEW: Secondary sclerosing cholangitis is an emerging entity. Yet, because of the low incidence and varying etiologies of this disease, the literature is not robust. There are mainly case reports and small studies evaluating the disease. Our aim in this review is to bring the reader up to date with recent literature on secondary sclerosing cholangitis including the disease presentation, course, prognosis, and treatment options. RECENT FINDINGS: Numerous case reports have been published the last 5 years on secondary sclerosing cholangitis. We have divided them into infectious, drug-induced, ischemic, obstructive, and autoimmune etiologies. The bulk of the literature describes secondary sclerosing cholangitis in the critically ill patient. Secondary sclerosing cholangitis due to drugs or autoimmune causes seem to have the best prognosis. However, causes such as critical illness seem to have worse outcomes.
Authors: T Voigtländer; A A Negm; A S Schneider; C P Strassburg; M P Manns; J Wedemeyer; T O Lankisch Journal: Endoscopy Date: 2012-10-29 Impact factor: 10.093
Authors: Pascal Frei; Benjamin Misselwitz; Meher K Prakash; Alain M Schoepfer; Bettina M Prinz Vavricka; Beat Müllhaupt; Michael Fried; Kuno Lehmann; Rudolf W Ammann; Stephan R Vavricka Journal: World J Gastroenterol Date: 2014-05-21 Impact factor: 5.742
Authors: Thomas Weig; Mirjam I Schubert; Norbert Gruener; Michael E Dolch; Lorenz Frey; Jens Miller; Thorsten Johnson; Michael Irlbeck Journal: Eur J Med Res Date: 2012-12-22 Impact factor: 2.175
Authors: Silke Leonhardt; Wilfried Veltzke-Schlieker; Andreas Adler; Eckart Schott; Dennis Eurich; Wladimir Faber; Peter Neuhaus; Daniel Seehofer Journal: Medicine (Baltimore) Date: 2015-12 Impact factor: 1.817
Authors: Torben Kehl; Daniel Biermann; Andrea Briem-Richter; Gerhard Schoen; Jakob Olfe; Joerg S Sachweh; Lutz Fischer; Hansjoerg Schaefer; Rainer Kozlik-Feldmann; Urda Gottschalk Journal: PLoS One Date: 2021-03-25 Impact factor: 3.240
Authors: Fotios S Fousekis; Vasileios I Theopistos; Ioannis V Mitselos; Alexandros Skamnelos; Athanasios Kavvadias; Konstantinos H Katsanos; Dimitrios K Christodoulou Journal: J Clin Med Res Date: 2019-01-05